Hagemann, A.R.; Hagemann, I.S.; Mutch, D.G.; Devor, E.J.; Malmrose, P.K.; Zhang, Y.; Morrison, A.M.; Thiel, K.W.; Leslie, K.K.
Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer. Cancers 2025, 17, 598.
https://doi.org/10.3390/cancers17040598
AMA Style
Hagemann AR, Hagemann IS, Mutch DG, Devor EJ, Malmrose PK, Zhang Y, Morrison AM, Thiel KW, Leslie KK.
Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer. Cancers. 2025; 17(4):598.
https://doi.org/10.3390/cancers17040598
Chicago/Turabian Style
Hagemann, Andrea R., Ian S. Hagemann, David G. Mutch, Eric J. Devor, Paige K. Malmrose, Yuping Zhang, Abigail M. Morrison, Kristina W. Thiel, and Kimberly K. Leslie.
2025. "Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer" Cancers 17, no. 4: 598.
https://doi.org/10.3390/cancers17040598
APA Style
Hagemann, A. R., Hagemann, I. S., Mutch, D. G., Devor, E. J., Malmrose, P. K., Zhang, Y., Morrison, A. M., Thiel, K. W., & Leslie, K. K.
(2025). Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer. Cancers, 17(4), 598.
https://doi.org/10.3390/cancers17040598